GLUE
Price
$5.66
Change
-$0.10 (-1.74%)
Updated
Jan 17 closing price
Capitalization
347.42M
53 days until earnings call
LPTX
Price
$2.55
Change
-$0.03 (-1.16%)
Updated
Jan 17 closing price
Capitalization
97.71M
Ad is loading...

GLUE vs LPTX

Header iconGLUE vs LPTX Comparison
Open Charts GLUE vs LPTXBanner chart's image
Monte Rosa Therapeutics
Price$5.66
Change-$0.10 (-1.74%)
Volume$631.11K
Capitalization347.42M
Leap Therapeutics
Price$2.55
Change-$0.03 (-1.16%)
Volume$678.22K
Capitalization97.71M
GLUE vs LPTX Comparison Chart
Loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLUE vs. LPTX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Hold and LPTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (GLUE: $5.66 vs. LPTX: $2.55)
Brand notoriety: GLUE and LPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 46% vs. LPTX: 179%
Market capitalization -- GLUE: $347.42M vs. LPTX: $97.71M
GLUE [@Biotechnology] is valued at $347.42M. LPTX’s [@Biotechnology] market capitalization is $97.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 0 FA rating(s) are green whileLPTX’s FA Score has 0 green FA rating(s).

  • GLUE’s FA Score: 0 green, 5 red.
  • LPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, GLUE is a better buy in the long-term than LPTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 4 TA indicator(s) are bullish while LPTX’s TA Score has 4 bullish TA indicator(s).

  • GLUE’s TA Score: 4 bullish, 4 bearish.
  • LPTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, GLUE is a better buy in the short-term than LPTX.

Price Growth

GLUE (@Biotechnology) experienced а -0.79% price change this week, while LPTX (@Biotechnology) price change was -16.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

GLUE is expected to report earnings on May 08, 2025.

LPTX is expected to report earnings on Aug 11, 2023.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($347M) has a higher market cap than LPTX($97.7M). LPTX YTD gains are higher at: -11.304 vs. GLUE (-18.516). LPTX has higher annual earnings (EBITDA): -64.24M vs. GLUE (-121.07M). GLUE has more cash in the bank: 242M vs. LPTX (62.8M). LPTX has less debt than GLUE: LPTX (376K) vs GLUE (43.7M). GLUE has higher revenues than LPTX: GLUE (15M) vs LPTX (0).
GLUELPTXGLUE / LPTX
Capitalization347M97.7M355%
EBITDA-121.07M-64.24M188%
Gain YTD-18.516-11.304164%
P/E RatioN/AN/A-
Revenue15M0-
Total Cash242M62.8M385%
Total Debt43.7M376K11,622%
FUNDAMENTALS RATINGS
LPTX: Fundamental Ratings
LPTX
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLUELPTX
RSI
ODDS (%)
Bullish Trend 11 days ago
89%
Bearish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
85%
Bearish Trend 11 days ago
90%
Momentum
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 11 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
85%
Advances
ODDS (%)
Bullish Trend 16 days ago
87%
Bullish Trend 12 days ago
87%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
87%
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
Bearish Trend 11 days ago
89%
N/A
View a ticker or compare two or three
Ad is loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WWNPX162.202.43
+1.52%
Kinetics Paradigm No Load
TILRX28.900.40
+1.40%
Nuveen Large Cap Growth R
AAIEX15.140.10
+0.66%
American Beacon International Eq R5
WCFEX14.640.04
+0.27%
WCM Focused Emerging Mkts Ex Chn Inv
ICRNX9.67N/A
N/A
VY® CBRE Global Real Estate A

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with RXRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-1.82%
RXRX - GLUE
49%
Loosely correlated
+2.03%
CRSP - GLUE
45%
Loosely correlated
+0.57%
RCKT - GLUE
43%
Loosely correlated
+0.98%
BEAM - GLUE
41%
Loosely correlated
+0.17%
PLRX - GLUE
41%
Loosely correlated
-3.36%
More

LPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPTX has been loosely correlated with AXON. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if LPTX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPTX
1D Price
Change %
LPTX100%
-1.16%
AXON - LPTX
40%
Loosely correlated
+1.37%
AMRN - LPTX
35%
Loosely correlated
+0.72%
NRIX - LPTX
33%
Poorly correlated
-1.80%
GLUE - LPTX
31%
Poorly correlated
-1.82%
ABSI - LPTX
30%
Poorly correlated
+3.57%
More